Screener
Corbus Pharmaceuticals
CRBPCorbus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies for oncology and obesity.
$140.42M-1.4%
Earnings
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$1.7M
EPS estimate-$1.21
Competitors
By market cap
By revenue growth
Profile
Corbus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies for oncology and obesity. The company leverages well-understood biological pathways to create next-generation treatments, including antibody-drug conjugates for cancer and peripherally restricted receptor agonists for metabolic disorders.
Competitive position
A clinical-stage innovator targeting validated biological mechanisms with next-generation chemical and biological engineering to improve safety and efficacy over first-generation competitors.
GeographiesUnited States, Canada, European Union, United Kingdom, Australia
Customer segmentsPatients, Healthcare systems
Business modelR&D intensive, IP licensing
SuppliersContract manufacturing organizations (CMOs), Contract research organizations (CROs), Academic research institutions, Licensing partners
CustomersHospitals, Specialty pharmacies, Clinical trial participants
CountryUnited States of America
Listed2014
Employees19.0
CEOYuval Cohen
SectorHealthcare
IndustryBiotechnology
Websitecorbuspharma.com
FilingsSEC EDGAR
FAQ
- What is Corbus Pharmaceuticals's market cap?
- Corbus Pharmaceuticals (CRBP) has a market capitalization of $140.4M and trades on NASDAQ.
- Who are Corbus Pharmaceuticals's competitors?
- Corbus Pharmaceuticals's key competitors include Skye Bioscience, Viking Therapeutics, Inc., Pfizer Inc., and others. These companies compete in similar markets and product categories.
- Who does Corbus Pharmaceuticals partner with?
- Corbus Pharmaceuticals's notable partners include CSPC Pharmaceutical Group Limited, Jenrin Discovery, LLC, University of California, and others.
- What subsidiaries does Corbus Pharmaceuticals have?
- Corbus Pharmaceuticals's subsidiaries include Corbus Pharmaceuticals, Inc..
- Where is Corbus Pharmaceuticals headquartered?
- Corbus Pharmaceuticals is headquartered in United States of America and employs approximately 19 people. It has been publicly traded since 2014.